한글목차

일본의 미생물 배양 시장 규모는 2024년 10억 5,718만 달러에서 2033년에는 21억 8,582만 달러에 달할 것으로 예상되며, 예측 기간인 2025-2033년 동안 8.5%의 CAGR로 성장할 것으로 예상됩니다.

미생물 배양은 미생물을 배양하여 그 정체나 시료 내 개체수 또는 둘 다를 조사하는 방법입니다. 미생물학의 주요 진단 방법 중 하나입니다. 미생물 배양을 위해서는 pH, 대기 가스, 온도, 압력이 제어된 적절한 물리적 환경이 필요합니다. 미생물 배지의 준비는 영양소, 완충제, 삼투압 조절제, 선택적 억제제 또는 지시약을 혼합하여 미생물의 증식과 분화를 지원하는 한천 또는 국물을 만드는 것을 포함합니다. 이 과정은 부패 미생물이나 병원성 미생물을 모니터링하는 미생물 검사에서 일상적인 작업입니다.

시장 역학

촉진요인과 억제요인

감염병 유행

감염성 질환은 정확한 병원체 동정, 항균제 내성 검사, 질병 감시가 조기 진단, 치료, 발생 억제에 필수적이기 때문에 미생물 배양 기술에 대한 수요를 증가시킵니다.

일본 내 감염성 질환이 증가함에 따라 첨단 진단 도구, 연구 및 치료법 개발의 필요성이 증가하고 있습니다. 세균, 바이러스, 진균 감염증이 증가함에 따라 의료 제공자와 연구기관은 병원체를 정확하게 식별하고, 항생제 내성을 판단하고, 효과적인 치료 전략을 개발하기 위해 미생물 배양에 대한 의존도를 높이고 있습니다.

일본에서는 마이코플라스마 폐렴 환자 수가 크게 증가하고 있으며, 지난 10년간 이 시기의 환자 수가 가장 많은 것으로 나타났습니다. 폐렴은 일본 내 사망 원인 중 5위를 차지하고 있습니다. 예를 들어, 일본 국립감염증연구소의 데이터에 따르면 2024년 10월까지 1주일 동안 보고된 마이코플라스마 폐렴 환자 수는 전국 의료기관 1곳당 평균 2.01명으로 처음으로 2명을 넘어섰습니다. 이러한 감염증의 증가로 인해 배양장치 및 배양 보조제 등의 수요가 증가할 것으로 예상됩니다. 이처럼 감염병의 증가는 국내 시장 성장을 촉진할 것으로 예상됩니다.

오염의 위험과 일관성 없는 결과

오염의 위험과 일관성 없는 결과는 미생물 배양의 정확성과 신뢰성에 영향을 미쳐 일본 미생물 배양 시장의 성장을 저해할 것으로 예상됩니다. 배양액의 준비, 보관, 취급 시 오염은 잘못된 결과를 초래하여 진단 및 조사 결과의 질을 떨어뜨릴 수 있습니다. 일관성 없고 신뢰할 수 없는 결과는 미생물 검사의 효율성에 영향을 미칠 뿐만 아니라 오진의 위험을 증가시켜 공중 보건에 심각한 영향을 미칠 수 있습니다. 이는 치료 지연, 부적절한 항생제 사용, 결과에 대한 신뢰도 부족으로 이어져 결국 의료진과 연구자들에게 우려를 불러일으킬 수 있습니다.

일본의 미생물 배양 시장에 대해 조사했으며, 시장 역학, 지역 및 부문 분석, 경쟁 상황, 기업 프로파일 등의 정보를 전해드립니다.

목차

제1장 시장 소개와 범위

제2장 경영진 인사이트, 중요 사항

• 시장 하이라이트와 전략적 포인트
• 주요 동향과 향후 예측
• 발췌 : 제품 유형별
• 발췌 : 배양 유형별
• 발췌 : 일관성별
• 발췌 : 용도별

제3장 시장 역학

• 영향요인
  • 성장 촉진요인
    • 감염증 유행
    • 미생물학과 생명과학의 연구개발 투자 증가
  • 성장 억제요인
    • 배지 생산에 관한 엄격한 규제 프레임워크
    • 오염 리스크와 일관성 없는 결과
  • 기회
    • 배양이 어려운 미생물에 이용하는 혁신적인 배지의 가능성
  • 영향 분석

제4장 전략적 인사이트와 산업 전망

• 시장 리더, 파이오니어
  • 신흥 파이오니어와 저명 기업
  • 최대 판매 브랜드를 보유한 확립된 리더
  • 확립된 제품을 보유한 시장 리더
• CXO의 견해
• 최신 발전과 혁신
• 사례 연구/진행중인 연구
• 북미의 규제와 상환 상황
• Porter's Five Forces 분석
• 공급망 분석
• 특허 분석
• SWOT 분석
• 미충족 수요와 격차
• 시장 진입 및 확장을 위한 권장 전략
• 시나리오 분석 : 베스트 케이스, 기본 케이스, 워스트 케이스 예측
• 가격 분석과 가격 동향
• KOL(Key Opinion Leader)

제5장 미생물 배양 시장 : 제품 유형별

• 배양 장비
  • 바이오리액터
    • 바이오리액터 디바이스
    • 계측 기구
    • PH 센서
    • 용존산소 센서
    • 온도 센서
    • 기타
    • 분석 디바이스
    • 셀 카운터
    • 분광계
    • 기타
    • 멸균 장비
    • 인큐베이터
    • 기타
• 배양 보충제
• 계측 기구
  • PH 센서
  • 온도 센서
  • 용존산소 센서
  • 기타
• 배양 기구
  • 페트리 접시
  • 루프·바늘
  • 마이크로피펫
  • 원심분리기
  • 기타
• 분석 디바이스
  • 셀 카운터
  • 분광계
  • 기타

제6장 미생물 배양 시장 : 배양 유형별

• 진핵생물 배양
• 세균 배양

제7장 미생물 배양 시장 : 견고성별

• 액체 배지
• 고체 배지
• 반고체 배지

제8장 미생물 배양 시장 : 용도별

• 의약품
• 식품 및 음료 산업
• 수질 검사
• 화장품

제9장 경쟁 구도와 시장 포지셔닝

• 경쟁 구도 개요, 주요 시장 기업
• 시장 점유율 분석, 포지셔닝 매트릭스
• 전략적 파트너십, 인수합병
• 제품 포트폴리오의 주요 발전, 혁신
• 기업 벤치마크

제10장 기업 개요

• Merck KGaA
• Yokogawa Electric Corporation
• SATAKE MultiMix Corporation
• BEMARUBISHI CO., LTD.
• ABLE Corporation & Biott Corporation
• Eiken Chemical co. Lti.
• BioMerieux SA
• Thermo Fisher Scientific, Inc.
• Sartorius AG
• Kerry Group plc.

제11장 가정과 조사 방법

제12장 부록

영문목차

The Japan microbiology culture market reached US$ 1,057.18 million in 2024 and is expected to reach US$ 2,185.82 million by 2033, growing at a CAGR of 8.5% during the forecast period 2025-2033.

A microbiology culture, or microbial culture, is a method of growing a microbial organism to determine its identity, its abundance in a sample, or both. It is one of the primary diagnostic methods in microbiology. Growing a microbial culture requires an appropriate physical environment with controlled pH, atmospheric gases, temperature, and pressure. Microbial culture media preparation involves mixing nutrients, buffering agents, osmotic balance regulators, and selective inhibitors or indicators to create agar or broth that supports microbial growth and differentiation. This process is a routine task in microbiological testing for monitoring spoilage and pathogenic microbes.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Infectious Diseases

Infectious diseases increase the demand for microbiology culture technologies, as accurate pathogen identification, antimicrobial resistance testing, and disease surveillance become essential for early diagnosis, treatment, and outbreak control.

With the increasing number of infectious diseases in Japan there is an increasing need for advanced diagnostic tools, research, and treatment development. With the growing number of bacterial, viral, and fungal infections, healthcare providers and research institutions are relying more on microbiology cultures to accurately identify pathogens, determine antibiotic resistance, and develop effective treatment strategies.

Japan is experiencing a significant rise in mycoplasma pneumonia cases, with patient numbers reaching the highest levels for this time of year in the past decade. Pneumonia was the fifth leading cause of death in Japan. For instance, data from Japan's National Institute of Infectious Diseases showed that, for the week ending October 2024, an average of 2.01 cases per medical institution were reported nationwide, marking the first time this figure surpassed two cases per facility. This increase in the number of infectious diseases is expected to increase the demand for culture equipment, culture supplements, and other instruments. Thus, the increasing number of infectious diseases is expected to drive the country's market growth.

Risk of Contamination and Inconsistent Results

The risk of contamination and inconsistent results is expected to hinder the growth of the Japan microbiology culture market by affecting the accuracy and reliability of microbial cultures. Contamination during the preparation, storage, or handling of culture media can lead to false results, compromising the quality of diagnostics and research outcomes. Inconsistent or unreliable results not only impact the efficiency of microbiological testing but also increase the risk of misdiagnosis, which can have serious public health consequences. This can lead to delays in treatment, improper use of antibiotics, and a lack of confidence in the results, ultimately raising concerns among healthcare professionals and researchers.

Segment Analysis

The Japan microbiology culture Market is segmented based on the product type, culture type, consistency, and application.

Culture equipment in the product type segment is expected to dominate the microbiology culture market

Culture equipment in the product type segment is vital in the precise growth, isolation, and analysis of microorganisms. With the growing demand for advanced microbiological research, clinical diagnostics, and pharmaceutical development, the need for specialized culture equipment like incubators, autoclaves, and sterile handling instruments is becoming increasingly important.

Japan's advanced healthcare and biotechnology sectors require high-precision equipment to ensure the reliability of microbial culture processes. For various microbiology culturing and processing purposes, companies are introducing innovative microbiology culture solutions which is driving the segment's growth. For instance, in April 2023, Otsuka Techno Corporation, a subsidiary of Otsuka Pharmaceutical Factory, launched the OT-Algae, a resin-bag type microalgae culture device, as part of its environmentally friendly manufacturing efforts.

Competitive Landscape

The market players in the microbiology culture market are Merck KGaA, Yokogawa Electric Corporation, SATAKE MultiMix Corporation, B.E.MARUBISHI CO., LTD., ABLE Corporation & Biott Corporation, Eiken Chemical co. Lti., BioMerieux S.A., Thermo Fisher Scientific, Inc., Sartorius AG, and Kerry Group plc. among others.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, and product pipelines, and forecasts upcoming pharmaceutical advancements.
• Type Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient Type delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The Japan microbiology culture market report would provide approximately 42 tables, 33t figures, and 180 pages.

Target Audience 2024

• Manufacturers: Pharmaceutical, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

• 1.1. Objectives of the Report
• 1.2. Report Coverage & Definitions
• 1.3. Report Scope

2. Executive Insights and Key Takeaways

• 2.1. Market Highlights and Strategic Takeaways
• 2.2. Key Trends and Future Projections
• 2.3. Snippet by Product Type
• 2.4. Snippet by Culture Type
• 2.5. Snippet by Consistency
• 2.6. Snippet by Application

3. Dynamics

• 3.1. Impacting Factors
  • 3.1.1. Drivers
    • 3.1.1.1. Rising Prevalence of Infectious Diseases
    • 3.1.1.2. Increasing R&D Investments in Microbiology and Life Sciences
  • 3.1.2. Restraints
    • 3.1.2.1. Stringent Regulatory Framework for Culture Media Production
    • 3.1.2.2. Risk of Contamination and Inconsistent Results
  • 3.1.3. Opportunity
    • 3.1.3.1. Potential for Innovative Culture Media for Fastidious Microorganisms
  • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

• 4.1. Market Leaders and Pioneers
  • 4.1.1. Emerging Pioneers and Prominent Players
  • 4.1.2. Established leaders with largest selling Brand
  • 4.1.3. Market leaders with established Product
• 4.2. CXO Perspectives
• 4.3. Latest Developments and Breakthroughs
• 4.4. Case Studies/Ongoing Research
• 4.5. North America Regulatory and Reimbursement Landscape
• 4.6. Porter's Five Force Analysis
• 4.7. Supply Chain Analysis
• 4.8. Patent Analysis
• 4.9. SWOT Analysis
• 4.10. Unmet Needs and Gaps
• 4.11. Recommended Strategies for Market Entry and Expansion
• 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
• 4.13. Pricing Analysis and Price Dynamics
• 4.14. Key Opinion Leaders

5. Microbiology Culture Market, By Product Type

• 5.1. Introduction
  • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 5.1.2. Market Attractiveness Index, By Product Type
• 5.2. Culture Equipment*
  • 5.2.1. Introduction
  • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.2.3. Bioreactors
    • 5.2.3.1. Bioreactor Devices
    • 5.2.3.2. Measuring Instruments
    • 5.2.3.2.1. PH Sensors
    • 5.2.3.2.2. Dissolved Oxygen Sensors
    • 5.2.3.2.3. Temperature Sensors
    • 5.2.3.2.4. Others
    • 5.2.3.3. Analytical Devices
    • 5.2.3.3.1. Cell Counters
    • 5.2.3.3.2. Spectrometers
    • 5.2.3.3.3. Others
    • 5.2.3.4. Sterilization Equipment
    • 5.2.3.5. Incubators
    • 5.2.3.6. Others
• 5.3. Culture Supplements
• 5.4. Measuring Instruments
  • 5.4.1. PH Sensors
  • 5.4.2. Temperature Sensors
  • 5.4.3. Dissolved Oxygen Sensors
  • 5.4.4. Others
• 5.5. Culture Instruments
  • 5.5.1. Petri Dishes
  • 5.5.2. Loops & Needles
  • 5.5.3. Micropipettes
  • 5.5.4. Centrifuge
  • 5.5.5. Others
• 5.6. Analytical Devices
  • 5.6.1. Cell Counters
  • 5.6.2. Spectrometers
  • 5.6.3. Others

6. Microbiology Culture Market, By Culture Type

• 6.1. Introduction
  • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Culture Type
  • 6.1.2. Market Attractiveness Index, By Culture Type
• 6.2. Eukaryotic Culture*
  • 6.2.1. Introduction
  • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 6.3. Bacterial Culture

7. Microbiology Culture Market, By Consistency

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Consistency
  • 7.1.2. Market Attractiveness Index, By Consistency
• 7.2. Liquid Media*
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3. Solid Culture Media
• 7.4. Semi-solid Media

8. Microbiology Culture Market, By Application

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Application
• 8.2. Pharmaceuticals*
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Food & Beverage Industry
• 8.4. Water Testing
• 8.5. Cosmetics

9. Competitive Landscape and Market Positioning

• 9.1. Competitive Overview and Key Market Players
• 9.2. Market Share Analysis and Positioning Matrix
• 9.3. Strategic Partnerships, Mergers & Acquisitions
• 9.4. Key Developments in Product Portfolios and Innovations
• 9.5. Company Benchmarking

10. Company Profiles

• 10.1. Merck KGaA*
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio
    • 10.1.2.1. Product Description
    • 10.1.2.2. Product Key Performance Indicators (KPIs)
    • 10.1.2.3. Historic and Forecasted Product Sales
    • 10.1.2.4. Product Sales Volume
  • 10.1.3. Financial Overview
    • 10.1.3.1. Company Revenue's
    • 10.1.3.2. Geographical Revenue Shares
    • 10.1.3.3. Revenue Forecasts
  • 10.1.4. Key Developments
    • 10.1.4.1. Mergers & Acquisitions
    • 10.1.4.2. Key Product Development Activities
    • 10.1.4.3. Regulatory Approvals, etc.
  • 10.1.5. SWOT Analysis
• 10.2. Yokogawa Electric Corporation
• 10.3. SATAKE MultiMix Corporation
• 10.4. B.E.MARUBISHI CO., LTD.
• 10.5. ABLE Corporation & Biott Corporation
• 10.6. Eiken Chemical co. Lti.
• 10.7. BioMerieux S.A.
• 10.8. Thermo Fisher Scientific, Inc.
• 10.9. Sartorius AG
• 10.10. Kerry Group plc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

• 11.1. Data Collection Methods
• 11.2. Data Triangulation
• 11.3. Forecasting Techniques
• 11.4. Data Verification and Validation

12. Appendix

• 12.1. About Us and Services
• 12.2. Contact Us